Infigratinib N-Oxide Impurity - Request Quote
Infigratinib N-Oxide Impurity
| SZ CAT No: | SZ-I065002 |
| CAS No | NA |
| Mol.F. | C26H31Cl2N7O4 |
| Mol.Wt. | 576.5 |
| Inv. Status | Under Synthesis |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Infigratinib N-Oxide Impurity is chemically 1-(4-((6-(3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylureido)pyrimidin-4-yl)amino)phenyl)-4-ethylpiperazine 1-oxide. Infigratinib N-Oxide Impurity is supplied with detailed characterization data compliant with regulatory guideline. Infigratinib N-Oxide Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Infigratinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Infigratinib N-Oxide Impurity
Purchase Infigratinib N-Oxide Impurity
Infigratinib N-Oxide Impurity suppliers
Infigratinib N-Oxide Impurity manufacturers
Infigratinib N-Oxide Impurity price
Order Infigratinib N-Oxide Impurity
Enquire Infigratinib N-Oxide Impurity
Infigratinib N-Oxide Impurity cost
Infigratinib N-Oxide Impurity Supplier
Infigratinib N-Oxide Impurity Distributor
Infigratinib N-Oxide Impurity for Method Validation
Infigratinib Reference Standard
Infigratinib N-Oxide Impurity for ANDA Filing
Infigratinib N-Oxide Impurity for Forced Degradation Studies
Infigratinib N-Oxide Impurity Identification Standards
Infigratinib N-Oxide Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.